Depletion of Core Needle Biopsy Cellularity and DNA Content as a Result of Vigorous Touch Preparations
Authors:
- Natasha RekhtmanNRNatasha Rekhtman
- Sofia KaziSKSofia Kazi
- JinJuan YaoJYJinJuan Yao
- Snjezana DoganSDSnjezana Dogan
- Angela YannesAYAngela Yannes
- Oscar LinOLOscar Lin
- Mikhail SilkMSMikhail Silk
- Tarik SilkTSTarik Silk
- Jeremy C. DurackJDJeremy C. Durack
- 18 December 2014
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 139 (7) , 907-912
Abstract
Context: Touch preparations (TP) of core needle biopsies (CNBs) are used at some institutions for on-site assessment of CNB adequacy. In our clinical practice, we have encountered instances in which TPs resulted in substantial depletion of CNB cellularity. Objective: To examine the effect of increasingly vigorous TPs on cellularity and DNA content of CNBs. Design: Ex vivo CNBs (n = 56) were performed on resected lung and kidney tumor specimens. For each specimen, CNBs were performed in quadruplicate on tumor and nontumor tissue and subjected to 1 of 4 TP methods: imprint, 1-cm drag, 2-cm drag, or full-slide drag. Overall cellularity in TPs relative to corresponding CNBs was estimated semiquantitatively. DNA was extracted and quantified from 12 TPs and corresponding CNBs. Two cytopathologists performed a blinded diagnostic assessment of Diff-Quik–stained TPs. Results: Cellularity of imprint, 1-cm, 2-cm, and full-slide TPs represented, on average, 19%, 33%, 41%, and 46% of total CNB cellularity, respectively (p = .003). Average DNA content in imprint, 1-cm, and 2-cm TPs was 0.3 μg (range, 0.1–0.8 μg), 0.4 μg (range, 0.1–1 μg), and 0.6 μg (range, 0.2–1.3 μg), respectively, which represented on average 15%, 36%, and 50%, respectively, of total CNB DNA content. Diagnostic accuracy was not inferior for less-extensive TPs, compared with more-extensive TPs. Conclusions: Vigorous TPs may contain a substantial fraction of CNB cellularity and DNA content, whereas more-limited TPs are less disruptive to CNBs but remain suitable for cytologic assessment. We suggest avoiding excessively forceful TPs and, whenever clinically feasible, obtaining additional samples to ensure sufficient cellularity for potential ancillary studies.Keywords
This publication has 27 references indexed in Scilit:
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyArchives of Pathology & Laboratory Medicine, 2013
- Role of Fluorescence in situ Hybridization in Lung Cancer CytologyActa Cytologica, 2012
- Pathological Diagnosis and Classification of Lung Cancer in Small Biopsies and Cytology: Strategic Management of Tissue for Molecular TestingSeminars in Respiratory and Critical Care Medicine, 2011
- Compensation crisis related to the onsite adequacy evaluation during FNA procedures-Urgent proactive input from cytopathology community is critical to establish appropriate reimbursement for CPT code 88172 (or its new counterpart if introduced in the future)Cytojournal, 2010
- Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds?The Breast, 2004
- Accuracy of touch imprint cytology in diagnosing lung cancerCytopathology, 2004
- Diagnostic value and cost‐effectiveness of on‐site evaluation of fine‐needle aspiration specimens: Review of 5,688 casesDiagnostic Cytopathology, 2002
- Imprint Cytology of Core Needle Biopsy Specimens of Breast LesionsActa Cytologica, 2000
- Imprint Cytology in the Diagnosis of Helicobacter pyloriActa Cytologica, 2000
- Value of having a cytopathologist present during percutaneous fine-needle aspiration biopsy of lung: report of 55 cancer patients and metaanalysis of the literature.American Journal of Roentgenology, 1993